ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-90

  1. 1,081 Posts.
    lightbulb Created with Sketch. 103
    Lazy is abit harsh buddy, busy with other things than look at some random stock, but thankyou for the short conclusion.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.